Upgrade to SI Premium - Free Trial

faeth (FTH)

28.29 +0.53 (1.91%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Form 8-K Faeth Therapeutics, Inc. For: Jul 21 July 23, 2026 5:16 PM - SEC Filing Form 4 Faeth Therapeutics, Inc. For: Jul 21 Filed by: Parikh Anand Kiran July 23, 2026 4:15 PM - SEC Filing Form 4 Faeth Therapeutics, Inc. For: Jul 21 Filed by: Craver Josiah July 23, 2026 4:15 PM - SEC Filing Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 23, 2026 4:00 PM - BizWire Citizens Starts Faeth Therapeutics (FTH) at Market Outperform July 20, 2026 3:05 AM - StreetInsider Faeth Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 3, 2026 4:00 PM - BizWire Form 4 Faeth Therapeutics, Inc. For: Jun 29 Filed by: STEPHENSON BRIAN C July 1, 2026 8:10 PM - SEC Filing Form 4 Faeth Therapeutics, Inc. For: Jun 24 Filed by: STEPHENSON BRIAN C June 26, 2026 7:40 PM - SEC Filing Baird Starts Faeth Therapeutics (FTH) at Outperform June 25, 2026 4:08 PM - StreetInsider Form 4 Faeth Therapeutics, Inc. For: Jun 22 Filed by: STEPHENSON BRIAN C June 24, 2026 6:58 PM - SEC Filing Form 4 Faeth Therapeutics, Inc. For: Jun 22 Filed by: Parikh Anand Kiran June 24, 2026 6:55 PM - SEC Filing Form 3 Faeth Therapeutics, Inc. For: Jun 13 Filed by: STEPHENSON BRIAN C June 23, 2026 5:22 PM - SEC Filing Form SCHEDULE 13G Faeth Therapeutics, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC June 23, 2026 4:36 PM - SEC Filing Form SCHEDULE 13G Faeth Therapeutics, Inc. Filed by: S2G Investments, LLC June 23, 2026 4:01 PM - SEC Filing H.C. Wainwright Starts Faeth Therapeutics (FTH) at Buy June 22, 2026 6:07 AM - StreetInsider Form 8-K Faeth Therapeutics, Inc. For: Jun 15 June 18, 2026 5:13 PM - SEC Filing faeth (FTH) files mixed shelf June 18, 2026 4:04 PM - StreetInsider Form S-3ASR Faeth Therapeutics, Inc. June 18, 2026 4:02 PM - SEC Filing Sensei Biotherapeutics changes name to Faeth Therapeutics June 15, 2026 8:10 AM - StreetInsider Sensei Biotherapeutics Announces Name Change to Faeth Therapeutics, Focused on Advancing PIKTOR, an Oral Therapy Targeting One of the Most Frequently Altered Pathways in Cancer June 15, 2026 8:10 AM - BizWire Full Article List